Apyx Medical reports Renuvion study shows increased elastin, reduced inflammation at 180 days
APYX•Apyx Medical said a prospective clinical study of its Renuvion device found increased elastin and reduced inflammation at 180 days.
1. Study findings
The prospective clinical study, published in a peer-reviewed journal, found biopsy evidence of reduced inflammation and favorable tissue remodeling, with no safety signals tied to abnormal healing. Participants and physicians reported visible aesthetic improvement, high satisfaction and intent to recommend the treatment.
